Copyright
©The Author(s) 2024.
World J Gastrointest Oncol. Jul 15, 2024; 16(7): 3308-3320
Published online Jul 15, 2024. doi: 10.4251/wjgo.v16.i7.3308
Published online Jul 15, 2024. doi: 10.4251/wjgo.v16.i7.3308
Figure 3 Forest plots of tumor responses.
A: The pooled complete response rate; B: The pooled objective response rate; C: The pooled disease control rate.
- Citation: Han F, Wang XH, Xu CZ. Clinical benefits of transarterial chemoembolization combined with tyrosine kinase and immune checkpoint inhibitors for unresectable hepatocellular carcinoma. World J Gastrointest Oncol 2024; 16(7): 3308-3320
- URL: https://www.wjgnet.com/1948-5204/full/v16/i7/3308.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v16.i7.3308